KCT0006294尚未招募未知
A Prospective randomized multi-center study for efficacy of metallic biliary stent compared to plastic stent in patients receiving neoadjuvant chemotherapy for resectable pancreatic cancer
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 入组人数
- 196
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional Study
入排标准
- 年龄范围
- 20?(Year) 至 o Limit（—）
- 性别
- All
入选标准
- •1. Patients aged 20 years or older who have confirmed histologically or radiologically resectable pancreatic cancer
- •2. Patients with clinical obstruction symptoms and radiographically confirmed biliary obstruction related to malignant tumors
- •3. Patients receiving neoadjuvant chemotherapy before surgery
排除标准
- •1. Patients diagnosed as unresectable pancreatic cancer
- •2. Patients with biliary obstruction due to biliary cancer, not pancreatic cancer
- •3. Patients with duodenal obstruction
- •4. Patients with pancreatic cance and other cancers
- •5. Patients with severe uncontrolled infection
- •6. Patients with 3 or higher of performance score as the Eastern Cooperative Oncology Group
- •7. Patients who have not agreed with the informed consent
- •8. Patients who are technically unable to be undergone endoscopic procedures
研究者
相似试验
已完成
3 期
Prospective multicenter randomized trial on the effects of Lanthanum Carbonate in hemodialysis patients compared with Calcium Carbonate on coronary artery calcification: Landmark Subsidiary StudyHemodialysis patients with hyperphosphatemiaJPRN-UMIN000006816andmark Study Group400
进行中（未招募）
1 期
Multicenter prospective randomized trial of the effect of rivaroxaban on survival and development of complications of portal hypertension in patients with cirrhosisiver cirrhosisEUCTR2014-005523-27-ESINSTITUTO DE INVESTIGACIONES BIOMEDICAS AUGUST PI I SUNYER (IDIBAPS)160
已完成
不适用
Randomised prospective multicentre trial on the effect of early enteral nutrition on gut barrier permeability in severe acute pancreatitisDigestive SystemAcute pancreatitisSevere acute pancreatitisISRCTN12838218Barts and the London NHS Trust (UK)66
进行中（未招募）
不适用
A multi-centre randomised study to evaluate the efficacy of Betaferon-interferon-beta-1b (IFNB-1B) 500 mcg therapy in the induction of tolerance to IFNB in MS patients with neutralising antibodies (NAbs) to IFNB-1a (Rebif) - Betaferon NaB Anergy StudyMultiple sclerosis (MS) is an inflammatory demyelinating disease of the central nervous system of unknown aetiology. It is the commonest cause of disability in young adults. The prevalence in the UK is approximately 125/100,000 of the population with an annual incidence of 6/100,000. Approximately 80,000 individuals are affected with MS in the UK.EUCTR2005-005751-18-GBCL Biomedicine R&D Unit100
进行中（未招募）
1 期
Study of the efficacy of early intervention with secukinumab 300 mg s.c. compared to narrow-band UVB in patients with new-onset moderate to severe plaque psoriasisPlaque psoriasisMedDRA version: 20.0Level: LLTClassification code 10050576Term: Psoriasis vulgarisSystem Organ Class: 100000004858EUCTR2015-002423-26-EEovartis Pharma Services AG196